Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
1 August 1995 | Volume 123 Issue 3 | Pages 192-194
Objective: To investigate trends in the incidence of giant cell arteritis over a 42-year period in Olmsted County, Minnesota.
Design: Population-based incidence study.
Setting: Olmsted County, Minnesota.
Methods: All incidence cases of giant cell arteritis first diagnosed between 1950 and 1991 were identified using the unified record system at Mayo Clinic. Age- and sex-specific incidence rates were calculated using the number of incidence cases as the numerator and population estimates as the denominator. Overall rates were age-and sex-adjusted to the 1980 United States white population. The annual incidence rates were graphically illustrated using a 3-year centered moving average.
Results: Between 1950 and 1991, 125 Olmsted County residents (103 women and 22 men) were diagnosed with giant cell arteritis. The age- and sex-adjusted incidence per 100 000 persons 50 years of age or older was 17.8 (95% CI, 14.7 to 21.0); incidence was significantly higher in women (24.2 [CI, 19.5 to 28.9]) than in men (8.2 [CI, 4.8 to 11.6]). Age-specific incidence rates increased with age (P < 0.0001). The annual incidence rates increased significantly over the study period (P = 0.002) and appear to have clustered in five peak periods, which occurred about every 7 years. A significant calendar-time effect was identified; it predicted an increase in incidence of 2.6% (CI, 0.9% to 4.3%) every 5 years.
Conclusions: Our observation of a regular cyclic pattern in incidence rates over time supports the hypothesis of an infectious cause for giant cell arteritis. Similar studies in other populations are needed to confirm our findings.
Age- and sex-specific incidence rates were calculated using the number of incidence cases as the numerator and population estimates based on decennial census counts as the denominator; linear interpolation was used to estimate population counts for years between censuses. Overall rates were age- and sex-adjusted to the 1980 United States white population. Ninety-five percent CIs were computed for incidence rates. The annual incidence rates were graphically illustrated using a 3-year centered moving average to eliminate some of the random fluctuation over time. The month of onset of the first symptoms related to giant cell arteritis was used to calculate the season-specific incidence rates. A generalized linear model [7] with log-link function and Poisson error structure was used to evaluate the relation between log incidence (the dependent variable) and age, sex, and chronologic time (in 5-year intervals), two-way interaction terms, and higher-order polynomial terms for age and time. The models were fit using GLIM (Generalized Linear Interactive Modelling). The observations used for the regression analysis were the crude incidence rates for both sexes in the following age groups: 50 to 59 years, 60 to 69 years, 70 to 79 years, and 80 or more years; and in the following calendar time periods: 1950-1954, 1955-1959, 1960-1964, 1965-1969, 1970-1974, 1975-1979, 1980-1984, and 1985-1991. The midpoints of the age groups and the calendar time periods were used in the trend analysis.
Table 1 shows the age- and sex-specific incidence rates, the overall age-adjusted rates for each sex, and these same age-adjusted rates according to time periods. The best generalized linear model analysis of predictors of incidence showed a significant elevation of incidence in women compared with men (P < 0.0001), a significant increase with age (P < 0.0001), and a significant linear effect of calendar time (P = 0.002). This calendar-time effect predicted a 2.6% increase in incidence every 5 years (CI, 0.9% to 4.3%).
BRIEF COMMUNICATION
The Incidence of Giant Cell Arteritis in Olmsted County, Minnesota: Apparent Fluctuations in a Cyclic Pattern
The cause of giant cell arteritis is unknown. Many investigators have suggested that environmental factors, such as infectious agents, exposure to sunlight, and contact with birds may be involved in the pathogenesis of this condition [1, 2]. Population-based studies that provide the incidence rate of a disease over time can provide clues about etiologic or environmental factors that influence the risk for the disease. The incidence of giant cell arteritis has already been determined for the population of Olmsted County, Minnesota, from 1950 to 1985 [3]. We determined the incidence from 1986 to 1991 and analyzed the trends in incidence rates over 42 years to generate hypotheses about factors that may be related to the pathogenesis of giant cell arteritis.
Methods
![]()
Top
Methods
Results
Discussion
Author & Article Info
References
The details of our epidemiologic methods have been described previously [4]. Our unique medical records linkage system allows ready access to the medical records of all health care providers for the population of Olmsted County, Minnesota, including the Mayo Clinic and its affiliated hospitals; the Olmsted Medical Group and Olmsted Community Hospital; local nursing homes; and the few private practitioners. All medical records (inpatient and outpatient) of Olmsted County residents that showed a surgical index entry of temporal or occipital artery biopsy or a medical diagnosis of giant cell arteritis between 1986 and 1991 were reviewed, and information about clinical manifestations, laboratory findings, and disease course was collected. In cases where the diagnosis was questionable, three rheumatologists reviewed all of the medical information and reached a consensus. The medical records of all patients from the previous study (1950 to 1985) were also reviewed [3], and the two data sets were collated. The diagnoses of giant cell arteritis and polymyalgia rheumatica were made according to the 1990 American College of Rheumatology criteria [5] and the criteria of Chuang and colleagues [6], respectively. Only persons who had been residents of Olmsted County for at least 12 months before the diagnosis of giant cell arteritis were included as incidence cases.
Results
![]()
Top
Methods
Results
Discussion
Author & Article Info
References
Between 1950 and 1991, 125 Olmsted County residents (103 women and 22 men) were diagnosed with giant cell arteritis. Of these, 81 (64.8%) had giant cell arteritis alone and 44 (35.2%) also had polymyalgia rheumatica. One hundred and fifteen (92%) had positive temporal artery biopsies, and all fulfilled the 1990 American College of Rheumatology criteria for giant cell arteritis [5].
|
|
Discussion
|
|---|
|
|
|---|
Illnesses with cyclic frequencies are most often infectious. An infectious cause has been previously postulated for giant cell arteritis and polymyalgia rheumatica [1, 10, 11]. Several reports of conjugal cases have been described and interpreted as evidence of a possible infectious cause [12-14]. Also, the presence of antibodies to intermediate filaments in patients with polymyalgia rheumatica or giant cell arteritis may indicate a viral cause [15] because these antibodies have also been found in serum specimens from patients with viral diseases [16]. Like giant cell arteritis [3, 17-23], other conditions (such as multiple sclerosis) that are suspected of having a viral cause have been noted to have an increased incidence at higher latitudes [24]. This implicates an environmental cause, in particular an infectious agent, that operates with increasing effectiveness or is more common at northern latitudes.
We have shown a statistically significant increase in the incidence of giant cell arteritis over the past four decades. Moreover, ours is the first study to report a regular cyclic pattern in giant cell arteritis incidence rates over time. We wish to emphasize, however, that although these results are intriguing, they are hypothesis-generating, and similar studies in other populations are needed to confirm our observations. Nonetheless, our findings support the hypothesis of an infectious cause for giant cell arteritis, perhaps in a genetically predisposed host. We hope that our data will serve as a stimulus for further research into the cause of this condition.
Author and Article Information
|
|---|
|
|
|---|
References
|
|---|
|
|
|---|
1. Fessel WJ. Polymyalgia rheumatica, temporal arteritis, and contact with birds. Lancet. 1969; 2:1249-50.
2. O'Brien JP, Regan W. Are we losing focus on the internal elastic lamina in giant cell arteritis? Arthritis Rheum. 1992; 35:794-8.
3. Machado EB, Michet CJ, Ballard DJ, Hunder GG, Beard CM, Chu CP, et al. Trends in incidence and clinical presentation of temporal arteritis in Olmsted County, Minnesota, 1950-1985. Arthritis Rheum. 1988; 31:745-9.
4. Kurland LT, Molgaard CA. The patient record in epidemiology. Sci Am. 1981; 245:54-63.
5. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990; 33:1122-8.
6. Chuang TY, Hunder GG, Ilstrup DM, Kurland LT. Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med. 1982; 97:672-80.
7. McCullagh P, Nelder JA. Generalized Linear Models. 2d ed. London: Chapman and Hall; 1989.
8. Huston KA, Hunder GG, Lie JT, Kennedy RH, Elveback LR. Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study. Ann Intern Med. 1978; 88:162-7.
9. Bengtsson BA, Malmvall BE. Giant cell arteritis. Acta Med Scand Suppl. 1982; 658:1-102.
10. Elling H, Skinhoj P, Elling P. Hepatitis B virus and polymyalgia rheumatica: a search for HBsAg, HBsAb, HBcAb, HBeAg, and HBeAb. Ann Rheum Dis. 1980; 39:511-3.
11. Cimmino MA, Grazi G, Balistreri M, Accardo S. Increased prevalence of antibodies to adenovirus and respiratory syncytial virus in polymyalgia rheumatica. Clin Exp Rheumatol. 1993; 11:309-13.
12. Mathewson JA, Hunder GG. Giant cell arteritis in two brothers. J Rheumatol. 1986; 13:190-2.
13. Barrier JH, Brisseau JM, Lucas V, Maugard-Louboutin C, Groleau J, Grolleau JY. Giant cell arteritis in a conjugal pair (Letter). J Rheumatol. 1988; 15:383-4.
14. Hickstein DD, Gravelyn TR, Wharton M. Giant cell arteritis and polymyalgia rheumatica in a conjugal pair. Arthritis Rheum. 1981; 24:1448-50.
15. Dasgupta B, Duke O, Kyle V, Macfarlane DG, Hazleman BL, Panayi GS. Antibodies to intermediate filaments in polymyalgia rheumatica and giant cell arteritis: a sequential study. Ann Rheum Dis. 1987; 46:746-9.
16. Toh BH, Yildiz A, Sotelo J, Osung O, Holborow EJ, Kanakoudi F, et al. Viral infections and IgM autoantibodies to cytoplasmic intermediate filaments. Clin Exp Immunol. 1979; 37:76-82.
17. Boesen P, Sorensen SF. Giant cell arteritis, temporal arteritis, and polymyalgia rheumatica in a Danish county. A prospective investigation, 1982-1985. Arthritis Rheum. 1987; 30:294-9.
18. Franzen P, Sutinen S, von Knorring J. Giant cell arteritis and polymyalgia rheumatica in a region of Finland: an epidemiologic, clinical and pathologic study, 1984-1988. J Rheumatol. 1992; 19:273-6.
19. Nordborg E, Bengtsson BA. Epidemiology of biopsy-proven giant cell arteritis (GCA). J Intern Med. 1990; 227:233-6.
20. Friedman G, Friedman B, Benbassat J. Epidemiology of temporal arteritis in Israel. Isr J Med Sci. 1982; 18:241-4.
21. Gonzalez-Gay MA, Alonso MD, Aguero JJ, Bal M, Fernandez-Camblor B, Sanchez-Andrade A. Temporal arteritis in a northwestern area of Spain: study of 57 biopsy proven patients. J Rheumatol. 1992; 19:277-80.
22. Salvarani C, Macchioni PL, Zizzi F, Mantovani W, Rossi F, Castri C, et al. Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy. Arthritis Rheum. 1991; 34:351-6.
23. Smith CA, Fidler WJ, Pinals RS. The epidemiology of giant cell arteritis. Report of a ten-year study in Shelby County, Tennessee. Arthritis Rheum. 1983; 26:1214-9.
24. Warren S. Epidemiology of multiple sclerosis. In: Anderson DW, Schoenberg DG, eds. Neuroepidemiology: A Tribute to Bruce Schoenberg. Boca Raton: CRC Press; 1991:239-64.
This article has been cited by other articles:
![]() |
J Askling, L Klareskog, H Hjalgrim, E Baecklund, M Bjorkholm, and A Ekbom Do steroids increase lymphoma risk? A case-control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis Ann Rheum Dis, December 1, 2005; 64(12): 1765 - 1768. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Perfetto, A Moggi-Pignone, A Becucci, F Cantini, M Di Natale, R Livi, A Tempestini, and M Matucci-Cerinic Seasonal pattern in the onset of polymyalgia rheumatica Ann Rheum Dis, November 1, 2005; 64(11): 1662 - 1663. [Full Text] [PDF] |
||||
![]() |
R Alvarez-Lafuente, B Fernandez-Gutierrez, J A Jover, E Judez, E Loza, D Clemente, J A Garcia-Asenjo, and J R Lamas Human parvovirus B19, varicella zoster virus, and human herpes virus 6 in temporal artery biopsy specimens of patients with giant cell arteritis: analysis with quantitative real time polymerase chain reaction Ann Rheum Dis, May 1, 2005; 64(5): 780 - 782. [Abstract] [Full Text] [PDF] |
||||
![]() |
J M Calvo-Romero Giant cell arteritis Postgrad. Med. J., September 1, 2003; 79(935): 511 - 515. [Abstract] [Full Text] |
||||
![]() |
M Ramos-Casals, M Garcia-Carrasco, M P Brito, A Lopez-Soto, and J Font Autoimmunity and geriatrics: clinical significance of autoimmune manifestations in the elderly Lupus, May 1, 2003; 12(5): 341 - 355. [Abstract] [PDF] |
||||
![]() |
C. Nordborg, H. Johansson, V. Petursdottir, and E. Nordborg The epidemiology of biopsy-positive giant cell arteritis: special reference to changes in the age of the population Rheumatology, April 1, 2003; 42(4): 549 - 552. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Nordborg and C. Nordborg Giant cell arteritis: epidemiological clues to its pathogenesis and an update on its treatment Rheumatology, March 1, 2003; 42(3): 413 - 421. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Salvarani, F. Cantini, L. Boiardi, and G. G. Hunder Polymyalgia Rheumatica and Giant-Cell Arteritis N. Engl. J. Med., July 25, 2002; 347(4): 261 - 271. [Full Text] [PDF] |
||||
![]() |
E. Reinhold-Keller, K. Herlyn, R. Wagner-Bastmeyer, J. Gutfleisch, H. H. Peter, H. H. Raspe, and W. L. Gross No difference in the incidences of vasculitides between north and south Germany: first results of the German vasculitis register Rheumatology, May 1, 2002; 41(5): 540 - 549. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Helweg-Larsen, B. Tarp, N. Obel, and B. Baslund No evidence of parvovirus B19, Chlamydia pneumoniae or human herpes virus infection in temporal artery biopsies in patients with giant cell arteritis Rheumatology, April 1, 2002; 41(4): 445 - 449. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. Smetana and R. H. Shmerling Does This Patient Have Temporal Arteritis? JAMA, January 2, 2002; 287(1): 92 - 101. [Abstract] [Full Text] [PDF] |
||||
![]() |
M A Gonzalez-Gay, C Garcia-Porrua, M J Rivas, P Rodriguez-Ledo, and J Llorca Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period Ann Rheum Dis, April 1, 2001; 60(4): 367 - 371. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Reinhold-Keller, A. Zeidler, J. Gutfleisch, H. H. Peter, H. H. Raspe, and W. L. Gross Giant cell arteritis is more prevalent in urban than in rural populations: results of an epidemiological study of primary systemic vasculitides in Germany Rheumatology, December 1, 2000; 39(12): 1396 - 1402. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G I SCOTT and R. A WATTS Systemic vasculitis: epidemiology, classification and environmental factors Ann Rheum Dis, March 1, 2000; 59(3): 161 - 163. [Full Text] |
||||
![]() |
V. Petursdottir, H. Johansson, E. Nordborg, and C. Nordborg The epidemiology of biopsy-positive giant cell arteritis: special reference to cyclic fluctuations Rheumatology, December 1, 1999; 38(12): 1208 - 1212. [Abstract] [Full Text] [PDF] |
||||
![]() |
S E Gabriel The epidemiology of gender-discrepant Illness Lupus, June 1, 1999; 8(5): 339 - 345. [PDF] |
||||
![]() |
P. Duhaut, L. Pinède, H. Bornet, S. Demolombe-Ragué, C. Dumontet, J. Ninet, R. Loire, and J. Pasquier Biopsy proven and biopsy negative temporal arteritis: differences in clinical spectrum at the onset of the disease Ann Rheum Dis, June 1, 1999; 58(6): 335 - 341. [Abstract] [Full Text] |
||||
![]() |
L. K. Gordon and L. A. Levin Visual Loss in Giant Cell Arteritis JAMA, July 22, 1998; 280(4): 385 - 386. [Full Text] [PDF] |
||||
![]() |
G G Hunder Giant cell arteritis Lupus, May 1, 1998; 7(4): 266 - 269. [Abstract] [PDF] |
||||
![]() |
G. G. Hunder and C. M. Weyand Sonography in Giant-Cell Arteritis N. Engl. J. Med., November 6, 1997; 337(19): 1384 - 1386. [Full Text] |
||||
![]() |
C. VITALI, E. GALLUZZO, E. M CIANCIA, A. MORETTI, and S. MARCHI Giant cell arteritis of the leg in a patient with hepatitis C virus infection Ann Rheum Dis, November 1, 1997; 56(11): 697 - 698. [Full Text] |
||||
![]() |
M. A CIMMINO Genetic and environmental factors in polymyalgia rheumatica Ann Rheum Dis, October 1, 1997; 56(10): 576 - 577. [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||